Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Thai Agencies Urge Delay Of H1N1 Vaccine Trials As Virus Seed Mutates

This article was originally published in PharmAsia News

Executive Summary

Thailand's health agencies within the Ministry of Public Health have concluded clinical trials for a locally made H1N1 flu vaccine should be delayed because the seed virus has mutated. A university professor found the virus strain obtained from Russia had mutated and thus was unstable and unsuited for production. The professor said health agencies agreed to recommend the MPH ethics committee halt trials of the Russian seed virus, but allow trials to proceed using a separate seed virus obtained from China. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts